ENZALUTAMIDE for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 25,954 adverse event reports in the FDA FAERS database where ENZALUTAMIDE was used for Prostate cancer.
Most Reported Side Effects for ENZALUTAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 8,891 | 18.1% | 594 | 1,115 |
| Death | 6,680 | 13.6% | 6,677 | 702 |
| Malignant neoplasm progression | 4,696 | 9.5% | 1,482 | 695 |
| Prostatic specific antigen increased | 3,731 | 7.6% | 321 | 463 |
| Asthenia | 3,589 | 7.3% | 386 | 785 |
| Drug ineffective | 3,468 | 7.0% | 235 | 275 |
| Hot flush | 3,144 | 6.4% | 119 | 262 |
| Decreased appetite | 3,069 | 6.2% | 413 | 811 |
| Nausea | 2,898 | 5.9% | 264 | 554 |
| Dizziness | 2,776 | 5.6% | 201 | 503 |
| Diarrhoea | 2,470 | 5.0% | 209 | 473 |
| Underdose | 2,017 | 4.1% | 393 | 320 |
| Back pain | 1,997 | 4.1% | 185 | 356 |
| Arthralgia | 1,821 | 3.7% | 114 | 243 |
| Constipation | 1,629 | 3.3% | 136 | 296 |
Other Indications for ENZALUTAMIDE
Product used for unknown indication (9,434)
Hormone-refractory prostate cancer (8,881)
Prostate cancer metastatic (3,171)
Metastases to bone (439)
Neoplasm prostate (401)
Neoplasm malignant (297)
Hormone-dependent prostate cancer (289)
Bone cancer (213)
Prostate cancer stage iv (208)
Prostatic specific antigen increased (199)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)
DOCETAXEL (1,551)